课题基金 / 基金详情

去泛素化酶OTUB2与转录因子GATA2正反馈环路促进结肠癌转移的机制研究

批准号:
82072725
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
褚晓源
依托单位:
学科分类:
肿瘤复发与转移
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
褚晓源

项目摘要

结项摘要

褚晓源的其他基金

相似基金

相关文献

中文摘要
转录调控异常是恶性肿瘤的典型特征,在驱动肿瘤转移中发挥重要作用。大规模生信分析和预实验发现,GATA2可能是维持结肠癌异常转录组的核心转录因子,但其促进结肠癌侵袭转移的上下游调控机理尚不清楚。采用蛋白质谱和免疫共沉淀试验发现,GATA2可能被去泛素化酶OTUB2识别,在翻译后水平维持其蛋白稳定性;联合分析RNA-seq和ChIP-seq高通量测序结果则表明,结肠癌高表达的GATA2可能在转录水平激活OTUB2和上皮间质转化关键基因Vimentin等表达,促进高侵袭转移特性。因此提出科学假说:GATA2可能与OTUB2形成正反馈环路,通过去泛素化作用上调GATA2表达,持续激活其下游侵袭转移相关基因,导致肿瘤转移。本项目拟采用多种细胞分子生物学技术及结肠癌转移模型,揭示结肠癌侵袭转移的泛素化-转录调控环路新机制,发掘转移性结肠癌的精准干预新靶点。
英文摘要
Dysregulated transcriptional control is a hallmark of human malignancies and plays a major role in driving tumor metastasis. By massive bioinformatic analysis of the publically available transcriptome datasets, we identified a core transcription factor GATA2 that may dictate a large portion of the aberrantly expressed genes in colon cancers. GATA2 is highly elevated in colon cancer tissues to maintains cell motility and invasiveness, however its upstream and downstream regulatory mechanisms remain unknown. To this end, through mass spectrometry and co-immunoprecipitation assays, we have found a deubiquitinase OTUB2 that may potentially upregulate GATA2 at post-translational level. Moreover, GATA2 was found to directly regulate OTUB2 and several key genes that are essential for epithelial to mesenchymal transition at the transcriptional level by combined analysis of RNA-seq and ChIP-seq data. In light of these findings, we propose that GATA2 may form a positive feedback loop with OTUB2 to stabilize itself through deubiquitination, which subsequently leads to consistent activation of a pro-metastatic transcriptional profile to maintain colon cancer metastasis. To challenge this notion, a serial of molecular and cellular techniques will be applied to examine how GATA2 and OTUB2 regulate either other at both post-translational and transcriptional levels. We will also test how the GATA2-OTUB2 feedback circuit controls downstream target genes to empower tumor metastasis in vivo, which might identifies potential molecular targets actionable for treating metastatic colon cancers in clinical settings.
结肠癌恶性进展的机制,特别是侵袭转移的调控机制一直是研究热点。本项目通过生物信息学分析、分子生物学实验、体外实验、体内实验、高通量测序等手段,筛选出结肠癌重要转录因子GATA2,明确了GATA2的互作蛋白USP10发挥去泛素化酶功能抑制GATA2的泛素化修饰、稳定GATA2的蛋白水平,进而促进下游靶基因MERTK转录、促进结肠癌细胞转移的调控机制。本项目从转录水平、表观遗传学修饰水平及基因调控水平揭示结肠癌恶性进展,为结肠癌细胞转移提供了新的靶点。在本项目资助下共计发表SCI论文19篇,其中影响因子5.0以上6篇。
MZF1/SETD1A-FoxM1正反馈环路促进结直肠癌侵袭转移的机制研究
  • 批准号:
    81872042
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2018
  • 负责人:
    褚晓源
  • 依托单位:
FoxM1c-miR-149-FoxM1b/1c负反馈环路在结肠癌血管生成中的调控作用及分子机制研究
  • 批准号:
    81572457
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2015
  • 负责人:
    褚晓源
  • 依托单位:
叉头框蛋白M1(FOXM1)通过转录激活存活素(survivin)基因表达而参与结肠癌肝转移表型形成的分子机制研究
  • 批准号:
    81272394
  • 项目类别:
    面上项目
  • 资助金额:
    65.0万元
  • 批准年份:
    2012
  • 负责人:
    褚晓源
  • 依托单位:
国内基金
海外基金